MedTrace Logo

Hypertension in Long-Term Care Facilities

NCT03046420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2021-05-20

No results posted yet for this study

Summary

This study is exploratory in nature and seeks to describe hypertension diagnosis and management among patients in long-term care (LTC) facilities.

Specifically, the primary objective is to:

• Identify LTC patients who are diagnosed with hypertension and assess the management and different outcomes of proper control of BP regarding to incidence of falls, cognitive decline, kidney diseases, cardiovascular diseases and incidence of cerebrovascular accidents

The secondary objectives are to:

Describe treatment patterns of hypertension in LTC facilities

* Identify patients who are receiving non-pharmacological treatment and effectiveness of this modality of treatment.
* Identify different classes of drugs used to treat hypertension in patients staying at LTC facility
* Identify different drug adverse effects encountered by patients receiving medical treatment.
* Identify patients who achieved normal blood pressure according to current guidelines

Conditions

Interventions

OTHER

Chart review

This is a retrospective chart review study. The charts of patients who meet the inclusion criteria will be abstracted into a standardized electronic case report form, as described in Section 5. A standardized case report form for each patient will be created so as to collect uniform data. Charts data for one year back to the start date of data abstraction will be included in the study

Sponsors & Collaborators

  • Louisiana State University Health Sciences Center in New Orleans

    lead OTHER

Principal Investigators

  • Erwin Aguilar, PharmD, MPH · LSU Health Sciences Center in New Orleans

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-26
Primary Completion
2017-08-31
Completion
2018-06-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046420 on ClinicalTrials.gov